The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pembrolizumab vs paclitaxel as second-line treatment for Asian patients with PD-L1–positive advanced gastric or gastroesophageal cancer (GC) in the phase III KEYNOTE-063 trial.
 
Hyun Cheol Chung
Consulting or Advisory Role - Amgen; Beigene; Bristol-Myers Squibb; Celltrion; Gloria Biosciences; Lilly; Merck Serono; MSD; Quintiles; Taiho Pharmaceutical; Zymeworks
Speakers' Bureau - Foundation medicine; Lilly; Merck Serono
Research Funding - Amgen; Beigene; Bristol-Myers Squibb; GlaxoSmithKline; Lilly; Merck Serono; MSD; Taiho Pharmaceutical
 
Yoon-Koo Kang
Consulting or Advisory Role - ALX Oncology; Amgen; Astellas Pharma; Bristol-Myers Squibb; DAEHWA Pharmaceutical; Macrogenics; Merck Serono; Novartis; Ono Pharmaceutical; Surface Oncology; Taiho Pharmaceutical; Zymeworks
 
Zhendong Chen
No Relationships to Disclose
 
Yuxian Bai
No Relationships to Disclose
 
Wan Zamaniah Wan Ishak
Honoraria - Amgen; Eisai; Eisai; Ipsen; Lilly; Merck Sharp & Dohme; Merck Sharp & Dohme; Pfizer; Roche/Genentech
Consulting or Advisory Role - Celgene; Celgene; Eisai; Lilly; Merck Sharp & Dohme
Research Funding - AstraZeneca; Merck Sharp & Dohme; Roche/Genentech
Travel, Accommodations, Expenses - Celgene; Eisai; Lilly; Pfizer
 
Byoung Yong Shim
No Relationships to Disclose
 
Youngiee Park
No Relationships to Disclose
 
Dong-Hoe Koo
No Relationships to Disclose
 
Jin Wei LU
No Relationships to Disclose
 
Jianming Xu
No Relationships to Disclose
 
Pooja Bhagia
Employment - Merck
 
Shu Kuang
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Chie-Schin Shih
Employment - Merck
Research Funding - Exelixis (Inst)
Travel, Accommodations, Expenses - Exelixis (Inst)
 
Shukui Qin
No Relationships to Disclose